The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches.

作者: Maria Concetta Geloso , Valentina Corvino , Elisa Marchese , Alessia Serrano , Fabrizio Michetti

DOI: 10.3389/FNAGI.2017.00242

关键词:

摘要: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by non-cell autonomous motor neuron loss. While it generally believed that the onset takes place inside neurons, different cell types mediating neuroinflammatory processes are considered deeply involved in progression of disease. On these grounds, many treatments have been tested on ALS animals with aim inhibiting or reducing pro-inflammatory action microglia and astrocytes counteract Unfortunately, anti-inflammatory therapies only modestly successful. The non-univocal role played during stress injuries might explain this failure. Indeed, now well recognized that, ALS, displays phenotypes, from surveillant early stages, to activated states, M1 M2, expression respectively harmful protective genes later phases Consistently, inhibition microglial function seems be valid strategy if stages polarization taken into account, interfering reactivity specifically targeting pathways and/or potentiating trophic ones. In review, we will analyze features timing activation light M1/M2 phenotypes main mice models ALS. Moreover, also revise results obtained aimed unbalance ratio, shifting towards outcome.

参考文章(117)
Weihua Zhao, David R. Beers, Shaughn Bell, Jinghong Wang, Shixiang Wen, Robert H. Baloh, Stanley H. Appel, TDP-43 activates microglia through NF-κB and NLRP3 inflammasome Experimental Neurology. ,vol. 273, pp. 24- 35 ,(2015) , 10.1016/J.EXPNEUROL.2015.07.019
Mahmoud Kiaei, Khatuna Kipiani, Susanne Petri, Dong-Kug Choi, Junyu Chen, Noel Y. Calingasan, M. Flint Beal, Integrative role of cPLA2 with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis Journal of Neurochemistry. ,vol. 93, pp. 403- 411 ,(2005) , 10.1111/J.1471-4159.2005.03024.X
Yiangos Yiangou, Paul Facer, Pascal Durrenberger, Iain P Chessell, Alan Naylor, Chas Bountra, Richard R Banati, Praveen Anand, COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurology. ,vol. 6, pp. 12- 12 ,(2006) , 10.1186/1471-2377-6-12
Peter Klivenyi, Mahmoud Kiaei, Gabrielle Gardian, Noel Y. Calingasan, M. Flint Beal, Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. ,vol. 88, pp. 576- 582 ,(2003) , 10.1046/J.1471-4159.2003.02160.X
Ruben Orihuela, Christopher A McPherson, Gaylia Jean Harry, Microglial M1/M2 polarization and metabolic states British Journal of Pharmacology. ,vol. 173, pp. 649- 665 ,(2016) , 10.1111/BPH.13139
Savina Apolloni, Cinzia Montilli, Pamela Finocchi, Susanna Amadio, Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events FEBS Journal. ,vol. 276, pp. 354- 364 ,(2009) , 10.1111/J.1742-4658.2008.06796.X
Thomas Philips, Jeffrey D. Rothstein, Rodent Models of Amyotrophic Lateral Sclerosis Current Protocols in Pharmacology. ,vol. 69, ,(2015) , 10.1002/0471141755.PH0567S69
Genevieve Gowing, Mélanie Lalancette-Hébert, Jean-Nicolas Audet, Florence Dequen, Jean-Pierre Julien, Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase Experimental Neurology. ,vol. 220, pp. 267- 275 ,(2009) , 10.1016/J.EXPNEUROL.2009.08.021
A. Florence Keller, Mathieu Gravel, Jasna Kriz, Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice Experimental Neurology. ,vol. 228, pp. 69- 79 ,(2011) , 10.1016/J.EXPNEUROL.2010.12.010